The influence of cell effects is supported by studies that describe paracrine interactions between MSCs and osteosarcoma cells driving resistance to doxorubicin, whereby MSC-secreted IL-6 protects tumour cells by STAT3 activation from doxorubicin-induced apoptosis in vitro and in vivo [42]. This evidence concerns the gene STAT3 and osteosarcoma.